137 related articles for article (PubMed ID: 15480645)
1. Peripheral nerve schwannoma: two cases exhibiting increased FDG uptake in early and delayed PET imaging.
Hamada K; Ueda T; Higuchi I; Inoue A; Tamai N; Myoi A; Tomita Y; Aozasa K; Yoshikawa H; Hatazawa J
Skeletal Radiol; 2005 Jan; 34(1):52-7. PubMed ID: 15480645
[TBL] [Abstract][Full Text] [Related]
2. FDG-PET imaging for chronic expanding hematoma in pelvis with massive bone destruction.
Hamada K; Myoui A; Ueda T; Higuchi I; Inoue A; Tamai N; Yoshikawa H; Hatazawa J
Skeletal Radiol; 2005 Dec; 34(12):807-11. PubMed ID: 15834566
[TBL] [Abstract][Full Text] [Related]
3. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
4. Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign.
Benz MR; Czernin J; Dry SM; Tap WD; Allen-Auerbach MS; Elashoff D; Phelps ME; Weber WA; Eilber FC
Cancer; 2010 Jan; 116(2):451-8. PubMed ID: 19924789
[TBL] [Abstract][Full Text] [Related]
5. FDG PET/CT findings in recurrent malignant schwannoma.
Halac M; Cnaral F; Sait S; Ylmaz S; Kerim S; Sergülen D; Uslu I
Clin Nucl Med; 2008 Mar; 33(3):172-4. PubMed ID: 18287838
[TBL] [Abstract][Full Text] [Related]
6. Change of maximum standardized uptake value slope in dynamic triphasic [18F]-fluorodeoxyglucose positron emission tomography/computed tomography distinguishes malignancy from postradiation inflammation in head-and-neck squamous cell carcinoma: a prospective trial.
Anderson CM; Chang T; Graham MM; Marquardt MD; Button A; Smith BJ; Menda Y; Sun W; Pagedar NA; Buatti JM
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):472-9. PubMed ID: 25680593
[TBL] [Abstract][Full Text] [Related]
7. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
8. [18-FDG-PET in a case of recurrent malignant schwannoma].
Santaella Y; Borrego I; López J; Ortiz MJ; Vázquez R
Rev Esp Med Nucl; 2005; 24(2):127-30. PubMed ID: 15745683
[TBL] [Abstract][Full Text] [Related]
9. [Differentiation of malignant and benign superficial lymph nodes by dual time point 18F-FDG PET].
Su MG; Fan QP; Tian Y; Li FL; Yang XC; Li L; Fan CZ; Tian R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):517-20. PubMed ID: 19627018
[TBL] [Abstract][Full Text] [Related]
10. CT, MRI, and
Kim HY; Hwang JY; Kim HJ; Kim YK; Cha J; Park GM; Kim ST
Acta Radiol; 2017 Oct; 58(10):1222-1230. PubMed ID: 28068826
[TBL] [Abstract][Full Text] [Related]
11. Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET.
Chander S; Westphal SM; Zak IT; Bloom DA; Zingas AP; Joyrich RN; Littrup PJ; Taub JW; Getzen TM
Clin Nucl Med; 2004 Jul; 29(7):415-8. PubMed ID: 15192465
[TBL] [Abstract][Full Text] [Related]
12. The clinical efficacy of (18)F-FDG-PET/CT in benign and malignant musculoskeletal tumors.
Shin DS; Shon OJ; Han DS; Choi JH; Chun KA; Cho IH
Ann Nucl Med; 2008 Aug; 22(7):603-9. PubMed ID: 18756363
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography of schwannomas: emphasizing its potential in preoperative planning.
Beaulieu S; Rubin B; Djang D; Conrad E; Turcotte E; Eary JF
AJR Am J Roentgenol; 2004 Apr; 182(4):971-4. PubMed ID: 15039173
[TBL] [Abstract][Full Text] [Related]
14. Perineural spread in head and neck malignancies: clinical significance and evaluation with 18F-FDG PET/CT.
Paes FM; Singer AD; Checkver AN; Palmquist RA; De La Vega G; Sidani C
Radiographics; 2013 Oct; 33(6):1717-36. PubMed ID: 24108559
[TBL] [Abstract][Full Text] [Related]
15. Dual-time-point 18F-FDG PET for the evaluation of gallbladder carcinoma.
Nishiyama Y; Yamamoto Y; Fukunaga K; Kimura N; Miki A; Sasakawa Y; Wakabayashi H; Satoh K; Ohkawa M
J Nucl Med; 2006 Apr; 47(4):633-8. PubMed ID: 16595497
[TBL] [Abstract][Full Text] [Related]
16. Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
Higgins KA; Hoang JK; Roach MC; Chino J; Yoo DS; Turkington TG; Brizel DM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):548-53. PubMed ID: 21277108
[TBL] [Abstract][Full Text] [Related]
17. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
Schaefferkoetter JD; Carlson ER; Heidel RE
J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
[TBL] [Abstract][Full Text] [Related]
18. Schwannoma of the extremities: the role of PET in preoperative planning.
Ahmed AR; Watanabe H; Aoki J; Shinozaki T; Takagishi K
Eur J Nucl Med; 2001 Oct; 28(10):1541-51. PubMed ID: 11685498
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E; Ebied O
Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
[TBL] [Abstract][Full Text] [Related]
20. An intrathoracic schwannoma case in
Gültekin A; Aydoğmuş Ü; Arifoğlu H; Bir F; Yaylalı O
Hell J Nucl Med; 2020; 23(2):206-208. PubMed ID: 32716413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
